<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Complications and outcome of infective endocarditis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Complications and outcome of infective endocarditis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Complications and outcome of infective endocarditis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Denis Spelman, MBBS, FRACP, FRCPA, MPH</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Gabriel S Aldea, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Scott E Kasner, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Ann Bolger, MD, FACC, FAHA</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Daniel J Sexton, MD</a></dd><dt><span> </span>Deputy Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elinor L Baron, MD, DTMH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Susan B Yeon, MD, JD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 25, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Infective endocarditis (IE) is associated with a broad array of complications. The likelihood of complication(s) depends on several factors including the infecting pathogen, duration of illness prior to therapy, and underlying comorbidities [<a href="#rid1">1</a>]. Complications can occur before, during, and after completion of therapy.</p><p>It can be difficult to assess the true incidence of complications since case series are frequently retrospective. In one review including 223 episodes of IE, 57 percent of patients had one complication, 26 percent had two, 8 percent had three, 6 percent had four, 1 percent had five, and 1 percent had six or more complications [<a href="#rid2">2</a>].</p><p>Issues related to complications and outcome of IE will be reviewed here. Indications for surgery and timing of surgery in patients with complications of IE are discussed further separately. (See  <a class="medical medical_review" href="/z/d/html/2148.html" rel="external">"Surgery for left-sided native valve infective endocarditis"</a> and  <a class="medical medical_review" href="/z/d/html/2132.html" rel="external">"Surgery for prosthetic valve endocarditis"</a>.)</p><p>Other issues related to IE are discussed separately. (See related topics.)</p><p class="headingAnchor" id="H7139106"><span class="h1">COMPLICATIONS OF ENDOCARDITIS</span><span class="headingEndMark"> — </span>Complications of infective endocarditis (IE) include cardiac, metastatic, neurologic, renal, musculoskeletal, and pulmonary complications as well as complications related to systemic infection (including embolization, metastatic infection, and mycotic aneurysm). More than one complication can occur simultaneously.</p><p>Complications can also be considered based on pathogenesis (ie, embolic [such as cerebral infarct], local spread of infection [such as heart valve destruction], metastatic infection [such as vertebral osteomyelitis], and immune-mediated damage [such as glomerulonephritis]).</p><p>IE due to <em>Staphylococcus aureus</em> is associated with complications more frequently than other pathogens (stroke 21 versus 14 percent, systemic emboli 27 versus 18 percent, persistent bacteremia 17 versus 5 percent, and in-hospital mortality 22 versus 14 percent) [<a href="#rid3">3</a>].</p><p class="headingAnchor" id="H3"><span class="h2">Cardiac complications</span><span class="headingEndMark"> — </span>Cardiac complications are the most common complications in IE; they occur in up to half of patients [<a href="#rid4">4</a>].</p><p class="headingAnchor" id="H4"><span class="h3">Heart failure</span><span class="headingEndMark"> — </span>Heart failure is the most common cause of death due to IE in the modern era. The correlation between heart failure and mortality depends on several factors including the valve involved (aortic valve involvement is more likely to cause heart failure than mitral valve involvement), the pathogen involved (<em>S. aureus</em> infection increases the likelihood of heart failure), and whether the patient undergoes surgery for valve repair or replacement. Heart failure is the most common reason for cardiac surgery in patients with IE; indications for surgery in patients with cardiac complications are discussed further separately. (See  <a class="medical medical_review" href="/z/d/html/2148.html" rel="external">"Surgery for left-sided native valve infective endocarditis"</a> and  <a class="medical medical_review" href="/z/d/html/2132.html" rel="external">"Surgery for prosthetic valve endocarditis"</a>.)</p><p>The usual cause of heart failure in patients with IE is valvular insufficiency resulting from infection-induced valvular damage. Rarely, embolization of fragments of valvular vegetations into the coronary arteries or obstruction of the coronary ostia by vegetation or abscess can cause acute myocardial infarction and subsequent heart failure [<a href="#rid4">4</a>].</p><p class="headingAnchor" id="H5"><span class="h3">Perivalvular abscess</span><span class="headingEndMark"> — </span>Perivalvular abscess should be suspected in the setting of conduction abnormalities on electrocardiogram (ECG) and/or persistent bacteremia or fever despite appropriate antimicrobial therapy [<a href="#rid5">5</a>]. The reported incidence of perivalvular abscess among patients with IE is 30 to 40 percent [<a href="#rid6">6-8</a>]. The aortic valve and its adjacent annulus are more susceptible to abscess formation and associated complications than the mitral valve and annulus [<a href="#rid6">6-8</a>]. This was illustrated in an autopsy study including 95 patients with native valve endocarditis; annular extension of infection was more common in patients with aortic valve compared with mitral valve endocarditis (41 versus 6 percent) [<a href="#rid6">6</a>].</p><p>Perivalvular abscesses can extend into adjacent cardiac conduction tissues, leading to heart block. Involvement of the conducting system is most common in the setting of aortic valve infection, especially when there is involvement of the valve ring between the right and non-coronary cusp; this anatomic site overlies the intraventricular septum that contains the proximal ventricular conduction system. Rarely, perivalvular infection can result in extrinsic coronary compression and can cause acute coronary syndrome [<a href="#rid9">9</a>]. (See  <a class="medical medical_review" href="/z/d/html/52.html" rel="external">"Diagnosis of acute myocardial infarction"</a>.)</p><p>Perivalvular abscess is associated with increased risk of systemic embolization and death. In one study including 73 patients with IE, the embolization rate was approximately twice as high among patients with perivalvular abscess (64 versus 30 percent) [<a href="#rid7">7</a>]. Another study including 118 patients with IE noted higher mortality among patients with perivalvular abscess (23 versus 14 percent) [<a href="#rid8">8</a>]. In addition, the presence of moderate or severe regurgitation is associated with higher mortality rate [<a href="#rid10">10</a>].</p><p>Data are conflicting regarding correlation between vegetation size and risk for perivalvular abscess. Large vegetation size had been implicated as a risk factor for perivalvular abscess in some series, although subsequent studies have shown no correlation [<a href="#rid7">7,11</a>]. Patients with IE involving congenital bicuspid aortic valves appear to be more prone to perivalvular complications than those with IE involving tricuspid aortic valves [<a href="#rid12">12</a>]. Injection drug use may be another risk factor for perivalvular abscess [<a href="#rid7">7</a>].</p><p>Transesophageal echocardiography (TEE) is more sensitive for detection of myocardial abscess than transthoracic echocardiography (TTE) [<a href="#rid13">13</a>]. In one study including 43 patients with perivalvular abscess documented at surgery or autopsy, the sensitivity, specificity, and positive and negative predictive values of TEE were 87, 95, 91, and 92 percent, respectively [<a href="#rid8">8</a>]. The sensitivity of TTE was much lower (28 percent), although the specificity was 99 percent. While TEE is more sensitive than TTE for detecting abscess, even TEE may miss abscess in difficult imaging situations where calcification, for example of the mitral annulus, obscures perivalvular tissues. Also, abscesses are more difficult to detect before they cavitate, and repeat TEE may be required if suspicion remains high. (See  <a class="medical medical_review" href="/z/d/html/5323.html" rel="external">"Role of echocardiography in infective endocarditis", section on 'Perivalvular abscess or fistula'</a>.)</p><p class="headingAnchor" id="H6"><span class="h3">Other cardiac complications</span><span class="headingEndMark"> — </span>Pericarditis (suppurative or nonsuppurative) can cause chest pain or cardiac tamponade [<a href="#rid14">14,15</a>]. (See  <a class="medical medical_review" href="/z/d/html/2128.html" rel="external">"Purulent pericarditis"</a> and  <a class="medical medical_review" href="/z/d/html/4940.html" rel="external">"Acute pericarditis: Clinical presentation and diagnosis"</a>.)</p><p>Intracardiac fistula (eg, aorta-atrial or aorta-ventricular) may develop due to extension of infection from the valve to adjacent myocardium. Rarely, this can lead to development of an aneurysm, aortic dissection, or myocardial perforation [<a href="#rid16">16,17</a>]. In one study including 4681 episodes of IE, the incidence of fistulous intracardiac complications was 1.6 percent [<a href="#rid18">18</a>].</p><p class="headingAnchor" id="H7"><span class="h2">Metastatic infection</span><span class="headingEndMark"> — </span>Forms of metastatic infection include embolization, metastatic abscess, and mycotic aneurysm.</p><p class="headingAnchor" id="H22613914"><span class="h3">Septic embolization</span><span class="headingEndMark"> — </span>General issues related to embolization in patients with IE will be reviewed here; issues related to embolization in patients with IE who undergo surgery are discussed separately, as are issues related to antithrombotic therapy. (See  <a class="medical medical_review" href="/z/d/html/2132.html" rel="external">"Surgery for prosthetic valve endocarditis"</a> and  <a class="medical medical_review" href="/z/d/html/1329.html" rel="external">"Antithrombotic therapy in patients with infective endocarditis"</a> and  <a class="medical medical_review" href="/z/d/html/2148.html" rel="external">"Surgery for left-sided native valve infective endocarditis", section on 'Vegetation characteristics and risk of embolization'</a>.)</p><p>Embolization with clinical sequelae has been described in 13 to 44 percent of patients with IE; in most cases, embolization occurs prior to clinical presentation but can occur after initiation of antimicrobial therapy [<a href="#rid19">19-21</a>]. Systemic embolization most commonly occurs in left-sided IE; pulmonic embolization most commonly occurs in right-sided IE. Systemic embolization can also occur in patients with right-sided IE and right-to-left shunt (for example, through a patent foramen ovale) [<a href="#rid22">22</a>].</p><p>Emboli can occlude or damage virtually any vessel in the systemic or pulmonary arterial circulation [<a href="#rid13">13</a>]. As a result, embolization can cause:</p><p class="bulletIndent1"><span class="glyph">●</span>Stroke</p><p class="bulletIndent1"><span class="glyph">●</span>Paralysis (due to embolic infarction of either the brain or spinal cord)</p><p class="bulletIndent1"><span class="glyph">●</span>Blindness (due to embolism or due to endophthalmitis as a result of bacteremic seeding)</p><p class="bulletIndent1"><span class="glyph">●</span>Ischemia of the extremities</p><p class="bulletIndent1"><span class="glyph">●</span>Splenic or renal infarction</p><p class="bulletIndent1"><span class="glyph">●</span>Pulmonary embolism</p><p class="bulletIndent1"><span class="glyph">●</span>Acute myocardial infarction</p><p></p><p>Endocarditis should be considered as a possible etiology in patients who present with signs or symptoms of systemic arterial embolization. Most patients with acute stroke do not have endocarditis, although the likelihood of IE is increased in relatively young patients and in patients with both cerebral and systemic arterial embolization [<a href="#rid23">23,24</a>].</p><p class="headingAnchor" id="H2993880"><span class="h4">Risk factors</span><span class="headingEndMark"> — </span>Risk factors for embolization include presence of left-sided vegetation, large vegetation size, microbiology, presence of antiphospholipid antibodies, age, diabetes, atrial fibrillation, and embolization prior to initiation of antibiotics [<a href="#rid25">25-32</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Left-sided vegetation</strong> – Embolization with clinical sequelae occurs more frequently in patients with left-sided than right-sided vegetations [<a href="#rid26">26</a>] and more frequently with mitral vegetations than aortic vegetations [<a href="#rid27">27</a>]. In one review including 281 patients with suspected IE, the incidence of embolic events was greater with mitral than aortic valve vegetations (25 versus 10 percent) [<a href="#rid27">27</a>]. The risk was highest among patients with a vegetation on the anterior mitral leaflet (37 percent), suggesting that the mechanical effects of abrupt leaflet excursion may contribute to the risk of embolization [<a href="#rid26">26</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Large vegetation size</strong> – One study including 384 patients with IE noted that vegetation size &gt;10 mm and severe mobility of the vegetation were predictors of new embolic events, even after adjustment for pathogen type. Vegetation size &gt;15 mm was a predictor of one-year mortality (adjusted relative risk 1.8, CI 1.10-2.82) [<a href="#rid31">31</a>]. In another study including 59 patients with IE due to <em>S. aureus</em>, the risk of embolization was greater in patients who had visible vegetations by both TTE and TEE compared with patients who had vegetations visualized only by TEE [<a href="#rid28">28</a>]. Another study noted that absence of valvular abnormalities on TTE may be associated with reduced incidence of complications [<a href="#rid29">29</a>]. (See  <a class="medical medical_review" href="/z/d/html/5323.html" rel="external">"Role of echocardiography in infective endocarditis", section on 'Prognostic markers'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Microbiology</strong> – The likelihood of symptomatic embolization is increased in the setting of IE due to fungal pathogens or <em>S. aureus</em>. In a review including 270 patients with fungal endocarditis, peripheral arterial embolization occurred in 45 percent of cases [<a href="#rid33">33</a>]. The most common sites were the cerebral circulation (17 percent) and femoral artery (16 percent). Another study including 384 patients with IE noted that emboli were more frequently observed in the setting of infection due to <em>S. aureus</em> and <em>Streptococcus bovis</em> infection [<a href="#rid31">31</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Presence of antiphospholipid antibodies</strong> – In one series including 91 patients with IE, the presence of antiphospholipid antibodies was associated with an increased risk of embolization (62 versus 23 percent); this may be due to increased endothelial cell activation, generation of thrombin, and defective fibrinolysis [<a href="#rid30">30</a>].</p><p></p><p class="headingAnchor" id="H8"><span class="h4">Effect of antibiotic therapy</span><span class="headingEndMark"> — </span>The risk of embolization declines after institution of appropriate antimicrobial therapy, and serious embolic events after institution of therapy are rare after two weeks [<a href="#rid19">19,34,35</a>]. In one study including 1437 patients with left-sided IE receiving appropriate therapy, the incidence of stroke fell from 4.8 to 1.7 per 1000 patient-days between the first and second week of therapy [<a href="#rid35">35</a>]. The potential role of surgery to reduce the risk of embolization in patients with left-sided IE is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/2148.html" rel="external">"Surgery for left-sided native valve infective endocarditis", section on 'Vegetation characteristics and risk of embolization'</a>.)</p><p class="headingAnchor" id="H7140322"><span class="h3">Metastatic abscess</span><span class="headingEndMark"> — </span>Development of metastatic abscess occurs as a sequela of septic embolization; this may occur in the spleen, kidneys, brain, and/or soft tissues (such as the psoas muscle).</p><p>Patients with splenic abscess do not always have significant abdominal pain or splenomegaly on physical examination; in some cases, the only clue(s) may be persistent fever and/or recurrent bacteremia during or after completion of antimicrobial therapy [<a href="#rid36">36</a>]. Splenic abscess frequently requires splenectomy for cure. In one series including 27 patients with splenic abscesses, mortality among 17 patients who underwent splenectomy was 18 percent; mortality among 10 patients who did not undergo splenectomy was 100 percent [<a href="#rid37">37</a>]. (See  <a class="medical medical_review" href="/z/d/html/7134.html" rel="external">"Splenomegaly and other splenic disorders in adults", section on 'Abscess and infarction'</a>.)</p><p>Solitary or multiple brain abscess(es), including microabscess(es), can occur in IE; purulent meningitis can also be observed. The presence of meningitis due to <em>S. aureus</em> should suggest the possibility of concomitant <em>S. aureus</em> endocarditis. In one series including 33 patients with <em>S. aureus</em> meningitis, IE was diagnosed in 21 percent of cases [<a href="#rid38">38</a>]. Abscess drainage is required to control local infection and to prevent ongoing bacteremia. (See  <a class="medical medical_review" href="/z/d/html/1279.html" rel="external">"Treatment and prognosis of bacterial brain abscess"</a>.)</p><p class="headingAnchor" id="H7140578"><span class="h3">Mycotic aneurysm</span><span class="headingEndMark"> — </span>Mycotic aneurysm can develop in the cerebral or systemic circulation in the setting of IE, usually at points of vessel bifurcation. Although some authors use the term "mycotic" to describe infected aneurysm regardless of etiology, we limit the use of this term to those aneurysms that develop when material originating in the heart causes arterial wall infection and, subsequently, dilation [<a href="#rid39">39</a>]. (See  <a class="medical medical_review" href="/z/d/html/2129.html" rel="external">"Overview of infected (mycotic) arterial aneurysm"</a>.)</p><p class="headingAnchor" id="H11"><span class="h2">Neurologic complications</span><span class="headingEndMark"> — </span>Manifestations of neurologic complications include:</p><p class="bulletIndent1"><span class="glyph">●</span>Embolic stroke</p><p class="bulletIndent1"><span class="glyph">●</span>Brain abscess or cerebritis</p><p class="bulletIndent1"><span class="glyph">●</span>Purulent or aseptic meningitis</p><p class="bulletIndent1"><span class="glyph">●</span>Acute encephalopathy</p><p class="bulletIndent1"><span class="glyph">●</span>Meningoencephalitis</p><p class="bulletIndent1"><span class="glyph">●</span>Cerebral hemorrhage (due to stroke or a ruptured mycotic aneurysm)</p><p class="bulletIndent1"><span class="glyph">●</span>Seizures (secondary to abscess or embolic infarction)</p><p></p><p>Symptomatic cerebrovascular complications occur in up to 35 percent of patients [<a href="#rid21">21,22,40-45</a>]. Silent cerebrovascular complications (including ischemia and microhemorrhage) may occur in up to 80 percent of patients [<a href="#rid21">21,46-48</a>].</p><p>Neurologic complications may be the presenting symptom in patients with IE, and the possibility of IE should be considered in patients who present with stroke, meningitis, or brain abscess. In addition, unexplained fever accompanying a stroke in a patient with valvular disease can be an important clue for IE. In one retrospective review including nearly 18,000 patients with IE, stroke risk was significantly increased beginning four months before the diagnosis of IE and lasting five months afterward; the risk of stroke was highest in the month after diagnosis of IE (absolute risk increase of 9.1 percent [95% CI 8.6-9.5 percent]) [<a href="#rid49">49</a>]. In a cohort study including more than 5700 patients with left-sided endocarditis, the risk of hemorrhagic stroke was increased; it was generally attributable to mediating factors including presence of a mechanical valves, atrial fibrillation, and anticoagulation medication [<a href="#rid50">50</a>]. </p><p>Among patients with IE, the incidence of cerebral emboli detected by magnetic resonance imaging (MRI) is markedly higher than the incidence of emboli detected based on clinical signs and symptoms [<a href="#rid21">21,48,51</a>]. In one study including 65 patients with IE, clinical findings consistent with embolism were observed in 20 percent of cases; among patients with no symptoms, emboli were detected on MRI in 46 percent of cases [<a href="#rid51">51</a>]. In another study including 60 patients with IE, clinical signs and symptoms of cerebral embolism were observed in 35 percent of cases; clinically silent emboli were detected on MRI in an additional 30 percent of patients [<a href="#rid21">21</a>].</p><p>In a study of 963 patients with IE, 7 percent had intracerebral hemorrhage [<a href="#rid52">52</a>]. Factors associated with intracerebral hemorrhage were low platelet count, severe valve regurgitation, ischemic stroke, systemic emboli, and the presence of a mycotic aneurysm.</p><p>Patient outcomes after a neurologic complication of IE are variable. In one study including 214 patients who underwent cardiac surgery for IE, 70 percent of patients with a preoperative stroke had full neurologic recovery; outcomes were worse in patients with stroke complicated by meningitis, abscess, or intracerebral hemorrhage [<a href="#rid44">44</a>]. Patient mortality in another series including 68 patients with stroke and IE was 50 percent at one year [<a href="#rid53">53</a>]. One study of 91 patients with <em>S. aureus</em> IE and neurologic manifestations noted mortality of 74 percent [<a href="#rid42">42</a>].</p><p class="headingAnchor" id="H7140072"><span class="h2">Renal complications</span><span class="headingEndMark"> — </span>Renal complications of IE include renal infarction or abscess following septic embolization, glomerulonephritis (due to deposition of immunoglobulins and complement in the glomerular membrane), and drug-induced acute interstitial nephritis. Acute renal failure, defined as a serum creatinine of ≥2 mg/dL (177 mcmol/L), has been described in up to one-third of patients [<a href="#rid54">54</a>]. Immune complex-mediated renal disease, commonly associated with IE in the pre-antibiotic era, is now uncommon, especially in patients whose infection is detected and treated early. (See  <a class="medical medical_review" href="/z/d/html/3054.html" rel="external">"Kidney disease in the setting of infective endocarditis or an infected ventriculoatrial shunt"</a>.)</p><p>Renal complications can also occur as a result of toxicity associated with administration of therapeutic drugs; this is particularly important in the setting of coadministration of <a class="drug drug_general" data-topicid="10037" href="/z/d/drug information/10037.html" rel="external">vancomycin</a> with aminoglycosides and among patients at the extremes of age. (See <a class="local">'Complications related to therapy'</a> below.)</p><p class="headingAnchor" id="H7139851"><span class="h2">Musculoskeletal complications</span><span class="headingEndMark"> — </span>Musculoskeletal complications of IE include vertebral osteomyelitis and septic arthritis. Back pain in patients with IE should prompt consideration of vertebral osteomyelitis, particularly in the setting of <em>S. aureus</em> infection [<a href="#rid55">55</a>]. An initial imaging study performed early in the presentation of acute IE may be negative; worsening back pain should prompt repeat imaging. (See  <a class="medical medical_review" href="/z/d/html/7663.html" rel="external">"Vertebral osteomyelitis and discitis in adults"</a>.)</p><p>Clues to the presence of septic arthritis in the setting of IE include involvement of multiple joints and involvement of the axial skeleton (eg, sacroiliac, pubic, or manubriosternal joints). Acute septic arthritis involving one or more joints may be the first clue to the presence of IE in a small percentage of patients, particularly for cases in which an organism with known propensity to cause IE (such as <em>S. aureus</em>, <em>S. viridans</em>, or non-group A beta-hemolytic streptococci) grows from a joint aspirate.</p><p class="headingAnchor" id="H339824203"><span class="h2">Pulmonary complications</span><span class="headingEndMark"> — </span>Pulmonary complications occur most commonly in the setting of right-sided endocarditis. Embolization of a vegetation from the tricuspid or pulmonary valve can result in pulmonary infection. Clinical presentations may include bacterial pneumonia, lung abscess, pyothorax, pleural effusion, and/or pneumothorax. Pulmonary complications have been associated with longer length of hospital stay, higher hospital costs, and increased hospital mortality [<a href="#rid56">56</a>].</p><p class="headingAnchor" id="H18"><span class="h2">Complications related to therapy</span><span class="headingEndMark"> — </span>Patients with infective endocarditis can develop a number of the complications associated with prolonged parenteral antimicrobial therapy or surgery:</p><p class="bulletIndent1"><span class="glyph">●</span>Aminoglycoside-induced ototoxicity or nephrotoxicity, particularly in patients who receive simultaneous treatment with <a class="drug drug_general" data-topicid="10037" href="/z/d/drug information/10037.html" rel="external">vancomycin</a> and aminoglycosides (see  <a class="medical medical_review" href="/z/d/html/7242.html" rel="external">"Pathogenesis and prevention of aminoglycoside nephrotoxicity and ototoxicity"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Postoperative mediastinitis or early postoperative prosthetic valve endocarditis (see  <a class="medical medical_review" href="/z/d/html/3806.html" rel="external">"Intravascular catheter-related infection: Epidemiology, pathogenesis, and microbiology"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Mediastinitis or early postoperative prosthetic valve endocarditis (see  <a class="medical medical_review" href="/z/d/html/7014.html" rel="external">"Postoperative mediastinitis after cardiac surgery"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Intravenous catheter-associated thrombosis (see  <a class="medical medical_review" href="/z/d/html/8195.html" rel="external">"Catheter-related upper extremity venous thrombosis in adults"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Drug fever (see  <a class="medical medical_review" href="/z/d/html/2738.html" rel="external">"Drug fever"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Allergic or idiosyncratic reactions to various antimicrobial agents – Some agents (such as beta-lactams) that are generally tolerable for short courses may be associated with significant reactions (acute interstitial nephritis) in the setting of long-term therapy</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bleeding due to disturbances in coagulation caused by anticoagulants (eg, in prosthetic valve endocarditis) (see  <a class="medical medical_review" href="/z/d/html/1329.html" rel="external">"Antithrombotic therapy in patients with infective endocarditis"</a>)</p><p></p><p class="headingAnchor" id="H19"><span class="h1">OUTCOME</span><span class="headingEndMark"> — </span>In the United States between 1980 and 2014, the mortality rate for endocarditis was 2.4 per 100,000 [<a href="#rid57">57</a>]. Among patients with infective endocarditis (IE), in-hospital mortality rate is 18 to 23 percent; the six-month mortality rate is 22 to 27 percent [<a href="#rid58">58-62</a>]. The outcomes in patients with neurologic complications are described above (see <a class="local">'Neurologic complications'</a> above). In a case series of 202 patients with IE in people who inject drugs, the all-cause mortality rate was 33.7 percent with lower mortality rates in those who had surgery or had referral for addiction therapy [<a href="#rid63">63</a>].</p><p>Some data suggest that the following characteristics appear to confer increased risk of mortality in patients with infective endocarditis:</p><p class="bulletIndent1"><span class="glyph">●</span>Microbiology (mortality is higher in the setting of <em>S. aureus</em> infection than streptococcal infection) [<a href="#rid59">59,61,64</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Heart failure [<a href="#rid60">60,62</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Diabetes mellitus [<a href="#rid59">59</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Embolization [<a href="#rid59">59,64</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Perivalvular abscess [<a href="#rid8">8,10,62</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Larger vegetation size [<a href="#rid31">31,64</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Female sex [<a href="#rid31">31</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Low serum albumin [<a href="#rid58">58</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Persistent bacteremia [<a href="#rid62">62</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Abnormal mental status [<a href="#rid61">61</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Poor surgical candidacy [<a href="#rid61">61</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Positive valve culture [<a href="#rid65">65</a>]</p><p></p><p>Echocardiographic findings may be useful predictors of outcome. One propensity-matched subset analysis including more than 700 patients with <em>S. aureus </em>left-sided native valve IE noted that intracardiac abscess and left ventricular ejection fraction &lt;40 percent were independent predictors of in-hospital mortality, and intracardiac abscess and valve perforation were independent predictors of one-year mortality [<a href="#rid66">66</a>].</p><p>The association between cardiac surgery, heart failure, and mortality risk is uncertain. In one prospective report, neither cardiac surgery nor heart failure was independently associated with in-hospital mortality [<a href="#rid59">59</a>]. However, among patients with moderate to severe heart failure, other studies have noted an association between cardiac surgery and lower mortality rate compared with medical therapy alone. In one study including approximately 260 patients, the presence of three risk factors (heart failure, periannular complications, and <em>S. aureus</em> infection) during the first 72 hours of hospitalization was predictive of need for urgent surgery or in-hospital mortality [<a href="#rid67">67</a>]. Subsequent prospective validation of the model noted that one risk factor conferred approximately 60 percent risk of adverse outcome; three risk factors conferred nearly 100 percent risk of adverse outcome.</p><p>Issues related to the association between cardiac surgery and clinical outcome are discussed further separately. (See  <a class="medical medical_review" href="/z/d/html/2148.html" rel="external">"Surgery for left-sided native valve infective endocarditis"</a>.)</p><p class="headingAnchor" id="H542101969"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/112042.html" rel="external">"Society guideline links: Treatment and prevention of infective endocarditis"</a>.)</p><p class="headingAnchor" id="H349561721"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/z/d/html/17037.html" rel="external">"Patient education: Endocarditis (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H3858106"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span>Complications of infective endocarditis (IE) include cardiac, neurologic, renal, musculoskeletal, and pulmonary complications as well as complications related to systemic infection (including embolization, metastatic infection, and mycotic aneurysm). More than one complication can occur simultaneously. (See <a class="local">'Complications of endocarditis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cardiac complications include heart failure, perivalvular abscess, pericarditis, and intracardiac fistula. Heart failure is the most common indication for cardiac surgery in patients with IE and is the most common cause of death. (See <a class="local">'Cardiac complications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Forms of metastatic infection include septic embolization, metastatic abscess, and mycotic aneurysm. Septic emboli can occlude or damage virtually any vessel in the systemic or pulmonary arterial circulation. Metastatic abscess can develop as a sequela of septic embolization; this may occur in the spleen, kidneys, brain, soft tissues, and/or lungs. Mycotic aneurysm can develop in the cerebral or systemic circulation in the setting of IE, usually at points of vessel bifurcation. (See <a class="local">'Metastatic infection'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Neurologic complications include stroke, brain abscess, meningitis, and other manifestations; these can be the presenting symptom in patients with IE. (See <a class="local">'Neurologic complications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Renal complications of IE include renal infarction or abscess following septic embolization, glomerulonephritis (due to deposition of immunoglobulins and complement in the glomerular membrane), and drug-induced acute interstitial nephritis. (See <a class="local">'Renal complications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Musculoskeletal complications of IE include vertebral osteomyelitis and septic arthritis. Back pain in patients with IE should prompt consideration of vertebral osteomyelitis, particularly in the setting of <em>S. aureus</em> infection. Clues to the presence of septic arthritis in the setting of IE include involvement of multiple joints and involvement of the axial skeleton (eg, sacroiliac, pubic, or manubriosternal joints). (See <a class="local">'Musculoskeletal complications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The six-month mortality rate among patients with IE ranges up to 27 percent. A number of factors appear to confer increased risk of mortality, including microbiology, heart failure, embolization, and candidacy for cardiac surgery. (See <a class="local">'Outcome'</a> above.)</p><p></p><p class="headingAnchor" id="H403344936"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Daniel Sexton, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Hoen B, Duval X. Infective endocarditis. N Engl J Med 2013; 369:785.</a></li><li><a class="nounderline abstract_t">Mansur AJ, Grinberg M, da Luz PL, Bellotti G. The complications of infective endocarditis. A reappraisal in the 1980s. Arch Intern Med 1992; 152:2428.</a></li><li><a class="nounderline abstract_t">Fowler VG Jr, Miro JM, Hoen B, et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 2005; 293:3012.</a></li><li><a class="nounderline abstract_t">Millaire A, Van Belle E, de Groote P, et al. Obstruction of the left main coronary ostium due to an aortic vegetation: survival after early surgery. Clin Infect Dis 1996; 22:192.</a></li><li><a class="nounderline abstract_t">Molavi A. Endocarditis: recognition, management, and prophylaxis. Cardiovasc Clin 1993; 23:139.</a></li><li><a class="nounderline abstract_t">Arnett EN, Roberts WC. Valve ring abscess in active infective endocarditis. Frequency, location, and clues to clinical diagnosis from the study of 95 necropsy patients. Circulation 1976; 54:140.</a></li><li><a class="nounderline abstract_t">Omari B, Shapiro S, Ginzton L, et al. Predictive risk factors for periannular extension of native valve endocarditis. Clinical and echocardiographic analyses. Chest 1989; 96:1273.</a></li><li><a class="nounderline abstract_t">Daniel WG, Mügge A, Martin RP, et al. Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. N Engl J Med 1991; 324:795.</a></li><li><a class="nounderline abstract_t">Attias D, Messika-Zeitoun D, Wolf M, et al. Acute coronary syndrome in aortic infective endocarditis. Eur J Echocardiogr 2008; 9:727.</a></li><li><a class="nounderline abstract_t">Cosmi JE, Tunick PA, Kronzon I. Mortality in patients with paravalvular abscess diagnosed by transesophageal echocardiography. J Am Soc Echocardiogr 2004; 17:766.</a></li><li><a class="nounderline abstract_t">Bayer AS. Infective endocarditis. Clin Infect Dis 1993; 17:313.</a></li><li><a class="nounderline abstract_t">Kahveci G, Bayrak F, Pala S, Mutlu B. Impact of bicuspid aortic valve on complications and death in infective endocarditis of native aortic valves. Tex Heart Inst J 2009; 36:111.</a></li><li><a class="nounderline abstract_t">Baddour LM, Wilson WR, Bayer AS, et al. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation 2015; 132:1435.</a></li><li><a class="nounderline abstract_t">Rose RL Jr, Higgins LS, Helgason AH. Bacterial endocarditis, pericarditis and cardiac tamponade. Am J Cardiol 1967; 19:447.</a></li><li><a class="nounderline abstract_t">Alió-Bosch J, Tornos-Mas MP, Soler-Soler J. Cardiac tamponade as an initial clinical presentation of infective endocarditis. Int J Cardiol 1987; 14:373.</a></li><li><a class="nounderline abstract_t">Parashara DK, Jacobs LE, Kotler MN, et al. Angina caused by systolic compression of the left coronary artery as a result of pseudoaneurysm of the mitral-aortic intervalvular fibrosa. Am Heart J 1995; 129:417.</a></li><li><a class="nounderline abstract_t">Abad C. Acute infectious mitroaortic endocarditis in association with acute aortic dissection. Surgical management of an unusual combination of diseases. Cardiovasc Surg 1995; 3:605.</a></li><li><a class="nounderline abstract_t">Anguera I, Miro JM, Vilacosta I, et al. Aorto-cavitary fistulous tract formation in infective endocarditis: clinical and echocardiographic features of 76 cases and risk factors for mortality. Eur Heart J 2005; 26:288.</a></li><li><a class="nounderline abstract_t">Steckelberg JM, Murphy JG, Ballard D, et al. Emboli in infective endocarditis: the prognostic value of echocardiography. Ann Intern Med 1991; 114:635.</a></li><li><a class="nounderline abstract_t">De Castro S, Magni G, Beni S, et al. Role of transthoracic and transesophageal echocardiography in predicting embolic events in patients with active infective endocarditis involving native cardiac valves. Am J Cardiol 1997; 80:1030.</a></li><li><a class="nounderline abstract_t">Snygg-Martin U, Gustafsson L, Rosengren L, et al. Cerebrovascular complications in patients with left-sided infective endocarditis are common: a prospective study using magnetic resonance imaging and neurochemical brain damage markers. Clin Infect Dis 2008; 47:23.</a></li><li><a class="nounderline abstract_t">Jones HR Jr, Siekert RG. Neurological manifestations of infective endocarditis. Review of clinical and therapeutic challenges. Brain 1989; 112 ( Pt 5):1295.</a></li><li><a class="nounderline abstract_t">Pruitt AA, Rubin RH, Karchmer AW, Duncan GW. Neurologic complications of bacterial endocarditis. Medicine (Baltimore) 1978; 57:329.</a></li><li><a class="nounderline abstract_t">Mohr JP, Caplan LR, Melski JW, et al. The Harvard Cooperative Stroke Registry: a prospective registry. Neurology 1978; 28:754.</a></li><li><a class="nounderline abstract_t">Di Salvo G, Habib G, Pergola V, et al. Echocardiography predicts embolic events in infective endocarditis. J Am Coll Cardiol 2001; 37:1069.</a></li><li><a class="nounderline abstract_t">Bayer AS, Bolger AF, Taubert KA, et al. Diagnosis and management of infective endocarditis and its complications. Circulation 1998; 98:2936.</a></li><li><a class="nounderline abstract_t">Rohmann S, Erbel R, Görge G, et al. Clinical relevance of vegetation localization by transoesophageal echocardiography in infective endocarditis. Eur Heart J 1992; 13:446.</a></li><li><a class="nounderline abstract_t">Fowler VG Jr, Sanders LL, Kong LK, et al. Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up. Clin Infect Dis 1999; 28:106.</a></li><li><a class="nounderline abstract_t">Sanfilippo AJ, Picard MH, Newell JB, et al. Echocardiographic assessment of patients with infectious endocarditis: prediction of risk for complications. J Am Coll Cardiol 1991; 18:1191.</a></li><li><a class="nounderline abstract_t">Kupferwasser LI, Hafner G, Mohr-Kahaly S, et al. The presence of infection-related antiphospholipid antibodies in infective endocarditis determines a major risk factor for embolic events. J Am Coll Cardiol 1999; 33:1365.</a></li><li><a class="nounderline abstract_t">Thuny F, Di Salvo G, Belliard O, et al. Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study. Circulation 2005; 112:69.</a></li><li><a class="nounderline abstract_t">Hubert S, Thuny F, Resseguier N, et al. Prediction of symptomatic embolism in infective endocarditis: construction and validation of a risk calculator in a multicenter cohort. J Am Coll Cardiol 2013; 62:1384.</a></li><li><a class="nounderline abstract_t">Ellis ME, Al-Abdely H, Sandridge A, et al. Fungal endocarditis: evidence in the world literature, 1965-1995. Clin Infect Dis 2001; 32:50.</a></li><li><a class="nounderline abstract_t">Fabri J Jr, Issa VS, Pomerantzeff PM, et al. Time-related distribution, risk factors and prognostic influence of embolism in patients with left-sided infective endocarditis. Int J Cardiol 2006; 110:334.</a></li><li><a class="nounderline abstract_t">Dickerman SA, Abrutyn E, Barsic B, et al. The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS). Am Heart J 2007; 154:1086.</a></li><li><a class="nounderline abstract_t">Weinstein L. Life-threatening complications of infective endocarditis and their management. Arch Intern Med 1986; 146:953.</a></li><li><a class="nounderline abstract_t">Robinson SL, Saxe JM, Lucas CE, et al. Splenic abscess associated with endocarditis. Surgery 1992; 112:781.</a></li><li><a class="nounderline abstract_t">Schlesinger LS, Ross SC, Schaberg DR. Staphylococcus aureus meningitis: a broad-based epidemiologic study. Medicine (Baltimore) 1987; 66:148.</a></li><li><a class="nounderline abstract_t">Bisdas T, Teebken OE. Mycotic or infected aneurysm? Time to change the term. Eur J Vasc Endovasc Surg 2011; 41:570; author reply 570.</a></li><li><a class="nounderline abstract_t">Garvey GJ, Neu HC. Infective endocarditis--an evolving disease. A review of endocarditis at the Columbia-Presbyterian Medical Center, 1968-1973. Medicine (Baltimore) 1978; 57:105.</a></li><li><a class="nounderline abstract_t">Harrison MJ, Hampton JR. Neurological presentation of bacterial endocarditis. Br Med J 1967; 2:148.</a></li><li><a class="nounderline abstract_t">Røder BL, Wandall DA, Espersen F, et al. Neurologic manifestations in Staphylococcus aureus endocarditis: a review of 260 bacteremic cases in nondrug addicts. Am J Med 1997; 102:379.</a></li><li><a class="nounderline abstract_t">Parrino PE, Kron IL, Ross SD, et al. Does a focal neurologic deficit contraindicate operation in a patient with endocarditis? Ann Thorac Surg 1999; 67:59.</a></li><li><a class="nounderline abstract_t">Ruttmann E, Willeit J, Ulmer H, et al. Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke 2006; 37:2094.</a></li><li><a class="nounderline abstract_t">García-Cabrera E, Fernández-Hidalgo N, Almirante B, et al. Neurological complications of infective endocarditis: risk factors, outcome, and impact of cardiac surgery: a multicenter observational study. Circulation 2013; 127:2272.</a></li><li><a class="nounderline abstract_t">Cooper HA, Thompson EC, Laureno R, et al. Subclinical brain embolization in left-sided infective endocarditis: results from the evaluation by MRI of the brains of patients with left-sided intracardiac solid masses (EMBOLISM) pilot study. Circulation 2009; 120:585.</a></li><li><a class="nounderline abstract_t">Klein I, Iung B, Labreuche J, et al. Cerebral microbleeds are frequent in infective endocarditis: a case-control study. Stroke 2009; 40:3461.</a></li><li><a class="nounderline abstract_t">Duval X, Iung B, Klein I, et al. Effect of early cerebral magnetic resonance imaging on clinical decisions in infective endocarditis: a prospective study. Ann Intern Med 2010; 152:497.</a></li><li><a class="nounderline abstract_t">Merkler AE, Chu SY, Lerario MP, et al. Temporal relationship between infective endocarditis and stroke. Neurology 2015; 85:512.</a></li><li><a class="nounderline abstract_t">Klein CF, Gørtz S, Wohlfahrt J, et al. Long-term Risk of Hemorrhagic Stroke in Patients With Infective Endocarditis: A Danish Nationwide Cohort Study. Clin Infect Dis 2019; 68:668.</a></li><li><a class="nounderline abstract_t">Grabowski M, Hryniewiecki T, Janas J, Stępińska J. Clinically overt and silent cerebral embolism in the course of infective endocarditis. J Neurol 2011; 258:1133.</a></li><li><a class="nounderline abstract_t">Salaun E, Touil A, Hubert S, et al. Intracranial haemorrhage in infective endocarditis. Arch Cardiovasc Dis 2018; 111:712.</a></li><li><a class="nounderline abstract_t">Anderson DJ, Goldstein LB, Wilkinson WE, et al. Stroke location, characterization, severity, and outcome in mitral vs aortic valve endocarditis. Neurology 2003; 61:1341.</a></li><li><a class="nounderline abstract_t">Conlon PJ, Jefferies F, Krigman HR, et al. Predictors of prognosis and risk of acute renal failure in bacterial endocarditis. Clin Nephrol 1998; 49:96.</a></li><li><a class="nounderline abstract_t">Speechly-Dick ME, Swanton RH. Osteomyelitis and infective endocarditis. Postgrad Med J 1994; 70:885.</a></li><li><a class="nounderline abstract_t">Bui JT, Schranz AJ, Strassle PD, et al. Pulmonary complications observed in patients with infective endocarditis with and without injection drug use: An analysis of the National Inpatient Sample. PLoS One 2021; 16:e0256757.</a></li><li><a class="nounderline abstract_t">Roth GA, Dwyer-Lindgren L, Bertozzi-Villa A, et al. Trends and Patterns of Geographic Variation in Cardiovascular Mortality Among US Counties, 1980-2014. JAMA 2017; 317:1976.</a></li><li><a class="nounderline abstract_t">Wallace SM, Walton BI, Kharbanda RK, et al. Mortality from infective endocarditis: clinical predictors of outcome. Heart 2002; 88:53.</a></li><li><a class="nounderline abstract_t">Chu VH, Cabell CH, Benjamin DK Jr, et al. Early predictors of in-hospital death in infective endocarditis. Circulation 2004; 109:1745.</a></li><li><a class="nounderline abstract_t">Hasbun R, Vikram HR, Barakat LA, et al. Complicated left-sided native valve endocarditis in adults: risk classification for mortality. JAMA 2003; 289:1933.</a></li><li><a class="nounderline abstract_t">Hill EE, Herijgers P, Claus P, et al. Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study. Eur Heart J 2007; 28:196.</a></li><li><a class="nounderline abstract_t">Wang A, Athan E, Pappas PA, et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA 2007; 297:1354.</a></li><li><a class="nounderline abstract_t">Rodger L, Glockler-Lauf SD, Shojaei E, et al. Clinical Characteristics and Factors Associated With Mortality in First-Episode Infective Endocarditis Among Persons Who Inject Drugs. JAMA Netw Open 2018; 1:e185220.</a></li><li><a class="nounderline abstract_t">Cabell CH, Pond KK, Peterson GE, et al. The risk of stroke and death in patients with aortic and mitral valve endocarditis. Am Heart J 2001; 142:75.</a></li><li><a class="nounderline abstract_t">García-Granja PE, López J, Vilacosta I, et al. Impact of Valve Culture in the Prognosis of Active Left-sided Infective Endocarditis. Clin Infect Dis 2019; 68:1017.</a></li><li><a class="nounderline abstract_t">Lauridsen TK, Park L, Tong SY, et al. Echocardiographic Findings Predict In-Hospital and 1-Year Mortality in Left-Sided Native Valve Staphylococcus aureus Endocarditis: Analysis From the International Collaboration on Endocarditis-Prospective Echo Cohort Study. Circ Cardiovasc Imaging 2015; 8:e003397.</a></li><li><a class="nounderline abstract_t">López J, Fernández-Hidalgo N, Revilla A, et al. Internal and external validation of a model to predict adverse outcomes in patients with left-sided infective endocarditis. Heart 2011; 97:1138.</a></li></ol></div><div id="topicVersionRevision">Topic 2142 Version 37.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23964952" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Infective endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1456853" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : The complications of infective endocarditis. A reappraisal in the 1980s.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15972563" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Staphylococcus aureus endocarditis: a consequence of medical progress.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8825007" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Obstruction of the left main coronary ostium due to an aortic vegetation: survival after early surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8416121" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Endocarditis: recognition, management, and prophylaxis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1277418" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Valve ring abscess in active infective endocarditis. Frequency, location, and clues to clinical diagnosis from the study of 95 necropsy patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2582833" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Predictive risk factors for periannular extension of native valve endocarditis. Clinical and echocardiographic analyses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1997851" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18579492" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Acute coronary syndrome in aortic infective endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15220902" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Mortality in patients with paravalvular abscess diagnosed by transesophageal echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8218670" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Infective endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19436803" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Impact of bicuspid aortic valve on complications and death in infective endocarditis of native aortic valves.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26373316" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6020315" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Bacterial endocarditis, pericarditis and cardiac tamponade.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3557717" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Cardiac tamponade as an initial clinical presentation of infective endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7832123" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Angina caused by systolic compression of the left coronary artery as a result of pseudoaneurysm of the mitral-aortic intervalvular fibrosa.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8745179" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Acute infectious mitroaortic endocarditis in association with acute aortic dissection. Surgical management of an unusual combination of diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15618052" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Aorto-cavitary fistulous tract formation in infective endocarditis: clinical and echocardiographic features of 76 cases and risk factors for mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2003709" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Emboli in infective endocarditis: the prognostic value of echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9352973" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Role of transthoracic and transesophageal echocardiography in predicting embolic events in patients with active infective endocarditis involving native cardiac valves.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18491965" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Cerebrovascular complications in patients with left-sided infective endocarditis are common: a prospective study using magnetic resonance imaging and neurochemical brain damage markers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2679968" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Neurological manifestations of infective endocarditis. Review of clinical and therapeutic challenges.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/580794" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Neurologic complications of bacterial endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/567291" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : The Harvard Cooperative Stroke Registry: a prospective registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11263610" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Echocardiography predicts embolic events in infective endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9860802" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Diagnosis and management of infective endocarditis and its complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1600980" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Clinical relevance of vegetation localization by transoesophageal echocardiography in infective endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10028079" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1918695" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Echocardiographic assessment of patients with infectious endocarditis: prediction of risk for complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10193740" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : The presence of infection-related antiphospholipid antibodies in infective endocarditis determines a major risk factor for embolic events.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15983252" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23906859" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Prediction of symptomatic embolism in infective endocarditis: construction and validation of a risk calculator in a multicenter cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11118386" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Fungal endocarditis: evidence in the world literature, 1965-1995.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16213607" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Time-related distribution, risk factors and prognostic influence of embolism in patients with left-sided infective endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18035080" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3516105" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Life-threatening complications of infective endocarditis and their management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1411951" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Splenic abscess associated with endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3821485" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Staphylococcus aureus meningitis: a broad-based epidemiologic study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21232995" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Mycotic or infected aneurysm? Time to change the term.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/622043" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Infective endocarditis--an evolving disease. A review of endocarditis at the Columbia-Presbyterian Medical Center, 1968-1973.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6021314" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Neurological presentation of bacterial endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9217620" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Neurologic manifestations in Staphylococcus aureus endocarditis: a review of 260 bacteremic cases in nondrug addicts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10086525" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Does a focal neurologic deficit contraindicate operation in a patient with endocarditis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16794213" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Neurological outcome of septic cardioembolic stroke after infective endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23648777" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Neurological complications of infective endocarditis: risk factors, outcome, and impact of cardiac surgery: a multicenter observational study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19652096" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Subclinical brain embolization in left-sided infective endocarditis: results from the evaluation by MRI of the brains of patients with left-sided intracardiac solid masses (EMBOLISM) pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19762695" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Cerebral microbleeds are frequent in infective endocarditis: a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20404380" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Effect of early cerebral magnetic resonance imaging on clinical decisions in infective endocarditis: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26163428" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Temporal relationship between infective endocarditis and stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29920590" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Long-term Risk of Hemorrhagic Stroke in Patients With Infective Endocarditis: A Danish Nationwide Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21222127" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Clinically overt and silent cerebral embolism in the course of infective endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29884600" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Intracranial haemorrhage in infective endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14638952" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Stroke location, characterization, severity, and outcome in mitral vs aortic valve endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9524779" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Predictors of prognosis and risk of acute renal failure in bacterial endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7870635" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Osteomyelitis and infective endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34478475" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Pulmonary complications observed in patients with infective endocarditis with and without injection drug use: An analysis of the National Inpatient Sample.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28510678" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Trends and Patterns of Geographic Variation in Cardiovascular Mortality Among US Counties, 1980-2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12067945" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Mortality from infective endocarditis: clinical predictors of outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15037538" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Early predictors of in-hospital death in infective endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12697795" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Complicated left-sided native valve endocarditis in adults: risk classification for mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17158121" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17392239" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Contemporary clinical profile and outcome of prosthetic valve endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30646383" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Clinical Characteristics and Factors Associated With Mortality in First-Episode Infective Endocarditis Among Persons Who Inject Drugs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11431660" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : The risk of stroke and death in patients with aortic and mitral valve endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30107544" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Impact of Valve Culture in the Prognosis of Active Left-sided Infective Endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26162783" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Echocardiographic Findings Predict In-Hospital and 1-Year Mortality in Left-Sided Native Valve Staphylococcus aureus Endocarditis: Analysis From the International Collaboration on Endocarditis-Prospective Echo Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21357640" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Internal and external validation of a model to predict adverse outcomes in patients with left-sided infective endocarditis.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
